AL-309

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameAL-309
Drug Alias NameAL-309D-SAL
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionPoly (ADP-Ribose) polymerase stimulantsNeuroprotectants
TargetsPoly (ADP-Ribose) polymerase
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAllon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllon Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A